Haverford Trust Co Has $709,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Haverford Trust Co lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 5.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,869 shares of the financial services provider’s stock after selling 308 shares during the period. Haverford Trust Co’s holdings in iShares Biotechnology ETF were worth $709,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Highline Wealth Partners LLC acquired a new position in shares of iShares Biotechnology ETF during the third quarter worth $30,000. Bbjs Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth $31,000. Ashton Thomas Securities LLC bought a new stake in iShares Biotechnology ETF during the 3rd quarter valued at $36,000. Voisard Asset Management Group Inc. acquired a new position in iShares Biotechnology ETF during the third quarter worth $59,000. Finally, Aptus Capital Advisors LLC raised its holdings in iShares Biotechnology ETF by 36.5% during the third quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after buying an additional 114 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 2.6 %

Shares of NASDAQ IBB opened at $140.09 on Friday. iShares Biotechnology ETF has a fifty-two week low of $116.70 and a fifty-two week high of $150.57. The firm’s 50-day simple moving average is $144.68 and its 200 day simple moving average is $141.56.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.